Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status
Anticancer Research · 2026
DOI: 10.21873/anticanres.18009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Yoh Yamaguchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-met, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Protein Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
- Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan; tatyoshi@ncc.go.jp.
- Department of Experimental Therapeutics, National Cancer Center Hospital, Tokyo, Japan.
Zitieren
APA
Yamaguchi, Y., Yoshida, T., Higashiyama, R. I., Masuda, K., Shinno, Y., Okuma, Y., Goto, Y., Horinouchi, H., Yamamoto, N., & Ohe, Y. (2026). Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status. Anticancer Research. https://doi.org/10.21873/anticanres.18009
Vancouver
Yamaguchi Y, Yoshida T, Higashiyama RI, Masuda K, Shinno Y, Okuma Y, et al. Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status. Anticancer Research. 2026. doi:10.21873/anticanres.18009
BibTeX
@article{Yamaguchi2026,
author = {Yamaguchi, Yoh and Yoshida, Tatsuya and Higashiyama, Ryoko Inaba and Masuda, Ken and Shinno, Yuki and Okuma, Yusuke and Goto, Yasushi and Horinouchi, Hidehito and Yamamoto, Noboru and Ohe, Yuichiro},
title = {Clinical Activity of MET-TKIs in METex14 Skipping NSCLC With Poor Performance Status},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18009}
}
EUVIMED